1. Cell Biology
  2. Immunology and Inflammation
Download icon

Diverse stimuli engage different neutrophil extracellular trap pathways

  1. Elaine F Kenny  Is a corresponding author
  2. Alf Herzig
  3. Renate Krüger
  4. Aaron Muth
  5. Santanu Mondal
  6. Paul R Thompson
  7. Volker Brinkmann
  8. Horst Von Bernuth
  9. Arturo Zychlinsky
  1. Max Planck Institute for Infection Biology, Germany
  2. Charité Medical School, Germany
  3. University of Massachusetts Medical School, United States
Research Article
  • Cited 295
  • Views 9,597
  • Annotations
Cite this article as: eLife 2017;6:e24437 doi: 10.7554/eLife.24437

Abstract

Neutrophils release neutrophil extracellular traps (NETs) which ensnare pathogens and have pathogenic functions in diverse diseases. We examined the NETosis pathways induced by five stimuli; PMA, the calcium ionophore A23187, nigericin, Candida albicans and Group B Streptococcus. We studied NET production in neutrophils from healthy donors with inhibitors of molecules crucial to PMA induced NETs including protein kinase C, calcium, reactive oxygen species, the enzymes myeloperoxidase (MPO) and neutrophil elastase. Additionally, neutrophils from chronic granulomatous disease patients, carrying mutations in the NADPH oxidase complex or a MPO-deficient patient were examined. We show that PMA, C. albicans and GBS use a related pathway for NET induction whereas ionophores require an alternative pathway but that NETs produced by all stimuli are proteolytically active, kill bacteria and composed mainly of chromosomal DNA. Thus, we demonstrate that NETosis occurs through several signalling mechanisms, suggesting that extrusion of NETs is important in host defence.

Article and author information

Author details

  1. Elaine F Kenny

    Department of Cellular Microbiology, Max Planck Institute for Infection Biology, Berlin, Germany
    For correspondence
    kenny@mpiib-berlin.mpg.de
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9985-5620
  2. Alf Herzig

    Department of Cellular Microbiology, Max Planck Institute for Infection Biology, Berlin, Germany
    Competing interests
    No competing interests declared.
  3. Renate Krüger

    Department of Paediatric Pneumology and Immunology, Outpatient Clinic for Primary Immunodeficiencies, Charité Medical School, Berlin, Germany
    Competing interests
    No competing interests declared.
  4. Aaron Muth

    Department of Biochemistry and Pharmacology, University of Massachusetts Medical School, Worcester, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0646-9964
  5. Santanu Mondal

    Department of Biochemistry and Pharmacology, University of Massachusetts Medical School, Worcester, United States
    Competing interests
    No competing interests declared.
  6. Paul R Thompson

    Department of Biochemistry and Pharmacology, University of Massachusetts Medical School, Worcester, United States
    Competing interests
    Paul R Thompson, P.R.T. is a consultant to Bristol-Myers Squibb..
  7. Volker Brinkmann

    Microscopy Core Facility, Max Planck Institute for Infection Biology, Berlin, Germany
    Competing interests
    No competing interests declared.
  8. Horst Von Bernuth

    Department of Paediatric Pneumology and Immunology, Outpatient Clinic for Primary Immunodeficiencies, Charité Medical School, Berlin, Germany
    Competing interests
    No competing interests declared.
  9. Arturo Zychlinsky

    Department of Cellular Microbiology, Max Planck Institute for Infection Biology, Berlin, Germany
    Competing interests
    No competing interests declared.

Funding

Max-Planck-Gesellschaft

  • Elaine F Kenny
  • Alf Herzig
  • Arturo Zychlinsky

National Institutes of Health (GM118112)

  • Aaron Muth
  • Santanu Mondal
  • Paul R Thompson

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: Blood samples were collected according to the Declaration of Helsinki with study participants providing written informed consent. All samples were collected with approval from the ethics committee-Charité -Universitätsmedizin Berlin.

Reviewing Editor

  1. Axel A Brakhage, Friedrich Schiller University Jena and Hans-Knöll-Institut, Germany

Publication history

  1. Received: December 20, 2016
  2. Accepted: June 1, 2017
  3. Accepted Manuscript published: June 2, 2017 (version 1)
  4. Version of Record published: July 4, 2017 (version 2)

Copyright

© 2017, Kenny et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 9,597
    Page views
  • 1,780
    Downloads
  • 295
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, Scopus, PubMed Central.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Download citations (links to download the citations from this article in formats compatible with various reference manager tools)

Open citations (links to open the citations from this article in various online reference manager services)

Further reading

    1. Cell Biology
    2. Structural Biology and Molecular Biophysics
    Elizabeth J Lawrence et al.
    Research Article

    Sjögren's Syndrome Nuclear Autoantigen 1 (SSNA1/NA14) is a microtubule-associated protein with important functions in cilia, dividing cells and developing neurons. However, the direct effects of SSNA1 on microtubules are not known. We employed in vitro reconstitution with purified proteins and TIRF microscopy to investigate the activity of human SSNA1 on dynamic microtubule ends and lattices. Our results show that SSNA1 modulates all parameters of microtubule dynamic instability - slowing down the rates of growth, shrinkage and catastrophe, and promoting rescue. We find that SSNA1 forms stretches along growing microtubule ends and binds cooperatively to the microtubule lattice. Furthermore, SSNA1 is enriched on microtubule damage sites, occurring both naturally, as well as induced by the microtubule severing enzyme spastin. Finally, SSNA1 binding protects microtubules against spastin's severing activity. Taken together, our results demonstrate that SSNA1 is both a potent microtubule stabilizing protein and a novel sensor of microtubule damage; activities that likely underlie SSNA1's functions on microtubule structures in cells.

    1. Cell Biology
    2. Immunology and Inflammation
    Dasmanthie DeSilva et al.
    Research Article

    Activation of T cells requires a rapid surge in cellular protein synthesis. However, the role of translation initiation in the early induction of specific genes remains unclear. Here, we show human translation initiation factor eIF3 interacts with select immune system related mRNAs including those encoding the T cell receptor (TCR) subunits TCRA and TCRB. Binding of eIF3 to the TCRA and TCRB mRNA 3’-untranslated regions (3’-UTRs) depends on CD28 coreceptor signaling and regulates a burst in TCR translation required for robust T cell activation. Use of the TCRA or TCRB 3’-UTRs to control expression of an anti-CD19 chimeric antigen receptor (CAR) improves the ability of CAR-T cells to kill tumor cells in vitro. These results identify a new mechanism of eIF3-mediated translation control that can aid T cell engineering for immunotherapy applications.